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Introduction {#sec001}
============

Polychlorinated biphenyls (PCBs) are ubiquitous contaminants in the environment and can accumulate in the bodies of animals and humans, resulting in toxicity to the reproductive, immune, nervous and endocrine systems \[[@pone.0160584.ref001]\]. For example, in Japan 1,684 people were poisoned after eating rice bran oil contaminated with PCBs, and more than 30 people died in 1968 \[[@pone.0160584.ref002]\]. Although PCBs became a main priority of the Stockholm International Convention in 2001 as a persistent organic pollutant (POPs) \[[@pone.0160584.ref003]\], PCBs present continued risks because of their persistence, refractory nature, and ease of accumulation.

Of the 209 PCBs congeners, 78 display axial chirality in their nonplanar conformation, and 19 are stable at ambient temperatures. Enantiomers of chiral PCBs have different biological and toxicological characteristics. Interestingly, the enantiomer fraction (EF) of PCB95 has opposite effects in fish (EF\<0.5) and bivalves (EF \>0.5) \[[@pone.0160584.ref004]\]. Moreover, enantiomers of PCB139 exhibit different potencies in inducing cytochrome P450 activity \[[@pone.0160584.ref005]\]. Therefore, it is necessary to evaluate the enantioselective effects of chiral PCBs on environmental problems and their risk to human health and the ecological environment.

Metabolomics is a relatively new omics technology involving the comprehensive measurement of small-molecule metabolites in organisms and has been widely used in the study of drug toxicity mechanisms and disease. Rat and zebrafish have recently been used as models for metabolomic and genomic research \[[@pone.0160584.ref006],[@pone.0160584.ref007]\], similarly to research on human diseases such as cancer \[[@pone.0160584.ref008]\] and neurodegenerative diseases \[[@pone.0160584.ref009]\]. Several metabolomic studies of the effects of PCBs in rats have demonstrated that PCBs and tetrachlorodibenzo---p-dioxin (TCDD) can lead to immune system disturbances, liver and nervous system dysfunction, and lipid metabolism perturbation \[[@pone.0160584.ref010]\]. However, few studies have reported metabolomics analysis of PCB enantiomers in organisms.

Therefore, in this study, we used ultra-high performance liquid chromatography and tandem mass spectrometry (UPLC-MS/MS) to study the enantioselective toxic effects of chiral PCB95 in zebrafish (*Danio rerio*) embryos based on metabolomics.

Materials and Methods {#sec002}
=====================

Reagents and materials {#sec003}
----------------------

A Milli-Q water purification system (Millipore, France) was used to prepare deionized water (18.2 MΩ). HPLC-grade 96% formic acid (MREDA, USA) and acetonitrile (Fisher Scientific, USA) were used as solvents. Methanol, *n*-hexane, and dichloromethane were HPLC grade and purchased from Fisher Scientific (USA). A mixed standard solution consisting of 26 compounds, including amino acids, organic acids, amines, and choline, was purchased from the National Institute of Metrology (China). The PCB95 standard was purchased from AccuStandard (purity\>98%; USA).

The enantiomers of chiral PCB95 were separated and quantified by Waters 2695 HPLC with an ultraviolet detector (USA) at 220 nm and a Lux 5 μm cellulose-3 column (250mm×4.6mm×5 μm; Phenomenex, USA) at 30°C. The flow rate was 1 mL/min, and the mobile phase was 100% of *n*-hexane. The injection volume was 20 μL. The order of elution of the enantiomers of PCB95 was confirmed using an online optical rotation detector (IBZMESSTECHNIK, Germany). The first eluted enantiomer was (-)-PCB95, and the second enantiomer was (+)-PCB95. The purity of the two enantiomers was greater than 98%. This method was validated previously in a comprehensive study \[[@pone.0160584.ref011]\].

Sample collection and preparation {#sec004}
---------------------------------

### Fish husbandry and embryo collection {#sec005}

Specific pathogen-free AB line zebrafish (*Danio rerio*) were cultured in a temperature-controlled laboratory (28±0.5°C) with a 14h:10h light/dark cycle. The conductivity of the water used for the zebrafish was 480+20 μS/cm, and the pH was adjusted to between pH 6.5 and 8.5 \[[@pone.0160584.ref012]\]. The fish were fed fresh frozen Artemia (Binhaijun Industry Co. Ltd, China) three times daily. Embryos were collected within 0.5 h post fertilization (hpf; male/female ratio of 1:1 or 1:2) and were rinsed with water.

### Exposure of zebrafish embryos {#sec006}

This study was performed in conformity with Chinese legislation and approved by the independent animal ethics committee at the Chinese Academy of Agricultural Sciences.

Chemical exposure was initiated at 5--6 hpf. The embryos were randomly allocated to three exposure groups: the racemic group, (-)-PCB95 group, and (+)-PCB95 group. The three exposure groups were each treated with three dose levels (high, middle, and low), yielding a total of 10 treatment groups, including one control group. All of the treatment groups were performed in ten replications (10 plastic petri dishes per group), with 20 embryos per sample and 200 embryos per treatment group. Zebrafish embryos were exposed for 72 h at 28 ± 0.5°C with a 14 h: 10 h light/dark cycle in constant temperature incubator. The treatment volume is 40 mL per petri dish, and the exposure solutions were completely renewed every 24 h \[[@pone.0160584.ref013]\]. Acetone was used as the solvent to prepare the stock solution, and the solvent concentration was 0.01%. The high-, middle-, and low-dose test solutions were 10, 1 and 0.1 μg/L respectively, and the control was only treated with 0.01% acetone. After the 72 h treatment, the embryos were collected in 1.5 mL tubes, washed three times, and snap-frozen in liquid nitrogen, and then stored at -80°C until extraction.

### Sample preparation {#sec007}

The embryo samples were thawed at room temperature and thoroughly homogenized in 100 μL of cold methanol on ice. Next, 140 μL of cold methanol, 195 μL of distilled water, and 240 μL of dichloromethane were added to the homogenate. The samples were then shook for 1 min, incubated on ice for 10 min, and centrifuged at 12000× *g* for 5 min at 4°C to remove protein and tissue debris \[[@pone.0160584.ref014],[@pone.0160584.ref015]\]. After centrifugation, 100 μL of the upper polar layer was transferred to a 1.5-mL glass vial and diluted 10-fold with methanol/water (50:50, v/v) containing 0.25% formic acid for UPLC-MS/MS analysis.

To evaluate the reliability of the preparation method, a standard solution containing 26 different types of compounds was added to blank extraction solvent at concentrations of 20, 100 or 200 μg/L before preparation. A quality control (QC) sample was prepared by mixing equal volumes from each embryo sample after preparation. The QC sample and the standard solution were analyzed before and during the sequence to estimate the method reliability.

UPLC-MS/MS analysis {#sec008}
-------------------

UPLC-MS/MS analysis was performed using a Waters UPLC system with a QTrap 6500 mass spectrometer (AB SCIEX, USA) in positive ion mode. The secondary mass spectrum information for 76 small polar compounds selected from the MassBank ([www.massbank.jp/](http://www.massbank.jp/)) database based on references was used for the MRM scanning module. The prepared samples were injected into an Xbridge C18 column (4.6mm×150mm×3.5 μm, Waters) at 25°C. The flow rate was 300 μL/min, and the mobile phase consisted of water with 0.1% formic acid (A) and acetonitrile (B). The gradient conditions were 5% B at 0--2 min, 5%--60% B over 2--10 min, and 60%--5% B over 10--16 min.

PCB95 analysis in water {#sec009}
-----------------------

To ensure the actual concentrations were consistent with the nominal concentrations, the water samples were measured at 0 and 24 h with 3 replications. Water (100 mL) was extracted with 20 ml of *n*-hexane in a separating funnel. The up-layer was transferred into 50-mL polyethylene centrifuge tube and dried by nitrogen at 35°C. Finally, the residue was redissolved in 0.1 mL of *n*-hexane for gas chromatography equipped with electron capture detector (GC-ECD) analysis. The GC-ECD (Agilent 7890 A; USA) analysis was performed using chiral Chirasil-Dex column (25 m×0.25 mm×0.25 μm). The injection temperature was 260°C with splitless stream sampling, and temperature program was as follows: 60°C hold for 2 min, 10°C/min to 150°C, 1°C/min to 180°C and hold for 20 min.

Data analysis {#sec010}
-------------

MarkerView1.2.1 (AB SCIEX) was used to extract peak information, regulation of migration time, and normalization. The normalized data were imported into SIMCA-P 11.0 software (Umetrics, Sweden) for multivariate analysis and IBM SPSS21.0 software (Chicago, IL, USA) for univariate analysis. The MetaboAnalyst 3.0 web service was used to perform pathway enrichment analysis and pathway topology analysis.

Results and Discussion {#sec011}
======================

Method validation {#sec012}
-----------------

To evaluate whether this method could be useful for the detection of diverse endogenous metabolites, a standard solution composed of 26 different standards, including amino acids, organic acids, amines, and choline, was analyzed under defined UPLC-MS/MS conditions before analyzing sequences of real samples. All compounds in the standard mixtures with the exception of glycine were clearly separated, suggesting that the UPLC-MS/MS method was suitable for analyzing a variety of metabolites. Of the 76 metabolites selected from the MassBank ([www.massbank.jp/](http://www.massbank.jp/)) database, 60 metabolites were detected in the embryos. As shown in [Fig 1](#pone.0160584.g001){ref-type="fig"}, most of the metabolites were eluted at 4 to 6 min; methionine, tyrosine, and pyroglutamic acid were eluted at 6 to 8 min. As isomers, leucine, and isoleucine were eluted at about 9 min. Tryptophan, phenylalanine, and hippurate have a common characteristic, containing a benzene ring, and they were eluted after 10 min. All of the metabolites were eluted before 12 min, and this rapid method fulfilled the requirements for adequate analysis of polar metabolites.

![Typical UPLC-MS/MS chromatogram of 60 polar metabolites in zebrafish embryos exposed to low-dose (-)-PCB 95.](pone.0160584.g001){#pone.0160584.g001}

The reliability of the preparation method was evaluated by measuring the recoveries of 26 standard compounds. Their recoveries ranged from 71.8% to 116%, except for glycine. Therefore, the preparation method was considered effective. The stability of analysis method was evaluated by relative standard deviation (RSD) of QC samples (*n* = 13). The RSDs were less than 30% for 53 metabolites, and the variation ranges in all QC samples were within 2 times the standard deviation (SD). The results showed that the above analytical methods were reliable and stable to explore organism information.

In water samples, a satisfactory recovery was obtained from 93.2--108.5% with RSDs of 4.3--12.8% at three spiked concentration levels (0.1, 1, and 10 μg/L). As shown in [Table 1](#pone.0160584.t001){ref-type="table"}, the actual concentrations of PCB95 were no less than 80% of the nominal concentrations within 24 hours and biotransformation was not found for the two enantiomers in water. So the concentrations of PCB95 were stable and there was no obvious difference in uptake during abiotic processes.

10.1371/journal.pone.0160584.t001

###### The concentrations of PCB95 in water samples.

![](pone.0160584.t001){#pone.0160584.t001g}

  Test Time   Theoretical concentration (μg/L)   Actual concentration (μg/L)          
  ----------- ---------------------------------- ----------------------------- ------ -------
  0 h         0.1                                0.09                          0.11   0.11
              1                                  1.03                          0.98   1.15
              1 0                                10.12                         9.84   10.30
  24 h        0.1                                0.08                          0.09   0.09
              1                                  0.91                          0.93   0.87
              1 0                                8.91                          9.40   9.05

Multivariate and univariate data analysis {#sec013}
-----------------------------------------

To directly analyze changes in the metabolome following treatment with PCB95, a supervised multivariate data analysis method, i.e., partial least squares discriminant analysis (PLS-DA), with Par-scaling was applied to the preprocessed data. This method was used to predict correlations between individual and control samples. PLS-DA is based on the PLS model, in which the dependent variable is selected to represent a class. PLS-DA is a powerful method for discrimination analysis between different groups and for identifying marker components that can explain differences among samples \[[@pone.0160584.ref016],[@pone.0160584.ref017]\].

The PLS-DA results ([Fig 2](#pone.0160584.g002){ref-type="fig"}) indicated that all PCB95-treated groups clustered at the same side and were clearly separated from the control group with R^2^X\>0.724 and Q^2^\>0.691. Groups exposed to PCB95 exhibited a clear separation trend, indicating that the differences between (+)- or (-)-PCB95 and the control group were more remarkable than the difference between the racemic group and the control group. The metabolic perturbations induced by different forms of PCB95 also occurred in the low-dose group (0.1 μg/L). It can be inferred that the effects of the two enantiomers of PCB95 may have been weakened when administered together, and further studies are needed to examine these variations.

![Partial least squares discriminant analysis (PLS-DA) score plots of data at 1 μg/L for all four groups (a), the control group versus the racemic group (b), the control group versus the (-)-PCB95 group (c), and the control group versus the (+)-PCB95 group (d).](pone.0160584.g002){#pone.0160584.g002}

To identify marker metabolites for these variations, variable importance in projection (VIP) analysis was performed to assess the importance of variables in the model with regard to Y \[[@pone.0160584.ref018]\]. If the VIP value was greater than 1, the variable was selected for further study. A total of 26 metabolites that differed between the treated and control groups were selected, and the VIP results were confirmed by S-plot analysis. In an S-plot, ideal biomarkers have high magnitude and high reliability, indicating a smaller risk of spurious correlations \[[@pone.0160584.ref019]\]. All of the selected metabolites were distributed on the edge of the S-plots with high magnitude and high reliability, indicating that these two types of analysis were in agreement with each other. Statistical analysis of variance (ANOVA) was then performed to select metabolites that differed significantly between groups (*p*\<0.05). Finally, we identified and quantified 22 metabolites from 26 potential markers using standards. The details of the potential markers are shown in [Table 2](#pone.0160584.t002){ref-type="table"}.

10.1371/journal.pone.0160584.t002

###### Detailed information of biomarkers in the PCB95-treated groups compared with the control group.

![](pone.0160584.t002){#pone.0160584.t002g}

  Common Name                                               MRM ion pair (m/z)   Retention Time    Chemical Formula   
  --------------------------------------------------------- -------------------- ----------------- ------------------ -----------------------
  Aspartate acid[^a^](#t002fn001){ref-type="table-fn"}      134.045/116.035      134.045/88.040    4.86               C~4~H~7~NO~4~
  Glutamic acid[^a^](#t002fn001){ref-type="table-fn"}       148.200/102.000      148.200/84.100    4.92               C~5~H~9~NO~4~
  Serine[^a^](#t002fn001){ref-type="table-fn"}              106.100/60.200                         4.80               C~3~H~7~NO~3~
  Histidine[^a^](#t002fn001){ref-type="table-fn"}           156.007/110.070                        4.56               C~6~H~9~N~3~O~2~
  Threonine[^a^](#t002fn001){ref-type="table-fn"}           120.100/74.100                         4.88               C~4~H~9~NO~3~
  Arginine[^a^](#t002fn001){ref-type="table-fn"}            175.200/70.000                         4.57               C~6~H~14~N~4~O~2~
  Alanine [^a^](#t002fn001){ref-type="table-fn"}            90.056/44.049                          4.88               C~3~H~7~NO~2~
  Tyrosine[^a^](#t002fn001){ref-type="table-fn"}            182.080/165.050      182.080/136.076   7.67               C~9~H~11~NO~3~
  Valine[^a^](#t002fn001){ref-type="table-fn"}              118.100/72.200                         5.85               C~5~H~11~NO~2~
  Methionine[^a^](#t002fn001){ref-type="table-fn"}          150.200/132.951      150.200/104.100   6.86               C~5~H~11~NO~2~S
  Phenylalanine[^a^](#t002fn001){ref-type="table-fn"}       166.090/103.056      166.090/120.080   9.86               C~9~H~11~NO~2~
  Leucine[^a^](#t002fn001){ref-type="table-fn"}             132.100/86.100                         9.18               C~6~H~13~NO~2~
  Isoleucine[^a^](#t002fn001){ref-type="table-fn"}          132.100/86.200       132.100/69.070    8.60               C~6~H~13~NO~2~
  Lysine[^a^](#t002fn001){ref-type="table-fn"}              147.100/84.100       147.100/130.000   4.53               C~6~H~14~N~2~O~2~
  Proline[^a^](#t002fn001){ref-type="table-fn"}             116.070/70.000                         5.11               C~5~H~9~NO~2~
  Cysteine[^a^](#t002fn001){ref-type="table-fn"}            241.031/151.983      241.031/120.011   4.73               C~6~H~12~N~2~O~4~S~2~
  Tryptophan[^a^](#t002fn001){ref-type="table-fn"}          205.200/188.300                        10.60              C~11~H~12~N~2~O~2~
  Taurine[^a^](#t002fn001){ref-type="table-fn"}             126.022/108.010      126.022/90.700    4.88               C~2~H~7~NO~3~S
  Glutamine[^a^](#t002fn001){ref-type="table-fn"}           147.077/130.050      147.077/84.045    4.82               C~5~H~10~N~2~O~3~
  γ-Aminobutyrate[^a^](#t002fn001){ref-type="table-fn"}     104.070/87.040       104.070/58.066    4.88               C~4~H~9~NO~2~
  Choline[^a^](#t002fn001){ref-type="table-fn"}             104.000/60.000                         4.80               C~5~H~14~NO
  Pyroglutamic acid[^a^](#t002fn001){ref-type="table-fn"}   130.050/112.900      130.050/84.045    7.10               C~5~H~7~NO~3~
  IMP                                                       349.055/137.046      349.055/119.036   5.36               C~10~H~13~N~4~O~8~P
  Pipecolic acid                                            130.100/84.100       130.100/56.200    4.46               C~6~H~11~NO~2~
  Betaine                                                   118.087/58.100       118.087/59.073    4.99               C~5~H~11~NO~2~
  N-Acetylornithine                                         175.100/115.300      175.100/70.000    4.52               C~7~H~14~N~2~O~3~

^a^ Represents the metabolites identified by standards.

Dose-response relationship and enantioselective toxic effects of PCB95 {#sec014}
----------------------------------------------------------------------

Significant metabolites were divided into 5 groups according to similar dose-response patterns, and each group has a common variation trend ([Fig 3](#pone.0160584.g003){ref-type="fig"}). To compare the relative contents of significant compounds in different treatment groups, average concentrations were graphed as histograms. To more intuitively descript the variation trend of each group, line chart of the representative metabolite was presented on the last panel. The most typical metabolites in each group were showed in [Fig 3](#pone.0160584.g003){ref-type="fig"} for easier understand. For Group a, including aspartate acid, phenylalanine, tryptophan, glutamine, glutamic acid, tyrosine, γ-aminobutyrate, betaine, choline, IMP, and N-acetylornithine, their average concentrations were higher in the PCB95-treated groups than those in the control group. These metabolites increased gradually from the control group to the middle-dose group, and then slightly decreased to the high-dose group ([Fig 3a](#pone.0160584.g003){ref-type="fig"}). These data demonstrate that low and middle doses induced the stress response in zebrafish embryos, and damage may occur to the embryos at high doses. For Group b, including serine, leucine, isoleucine, lysine, proline, valine, alanine, cysteine, threonine, and pipecolic acid, their average concentrations increased gradually from the control to the middle-dose group, and decreased to the high-dose group in the racemic and (-)-PCB95 groups. In contrast, these compounds were at equal or lower levels in the (+)-PCB95 group than those in the control group ([Fig 3b](#pone.0160584.g003){ref-type="fig"}). Therefore, these compounds may be labeled as markers for (+)-PCB95. However, further studies are needed to confirm this hypothesis. The levels of pyroglutamic acid and histidine were increased in the racemic group compared with the control group but decreased after only exposure to (-)-PCB95 or (+)-PCB95 ([Fig 3c](#pone.0160584.g003){ref-type="fig"}). As the dose of PCB95 gradually increased, methionine levels decreased only in high dose groups ([Fig 3d](#pone.0160584.g003){ref-type="fig"}). However, taurine exhibited complex variation patterns in different groups ([Fig 3e](#pone.0160584.g003){ref-type="fig"}).

![Average concentrations of typical significant metabolites with bigger variation trends in zebrafish embryos treated with different forms of chiral PCB95.\
The metabolites were separated into five groups (a, b, c, d and e) based on similar dose-response patterns, and different letters on the top of columns means significant differences with P\<0.05 (ANOVA).](pone.0160584.g003){#pone.0160584.g003}

The variation tendencies of potential markers among different groups at a concentration of 1 μg/L are shown in [Table 3](#pone.0160584.t003){ref-type="table"}. Alanine and threonine significantly increased in the racemic and (-)-PCB95 groups compared with the control group. In contrast, they decreased in the (+)-PCB95 group compared with other groups. These results not only indicate that (-)-and (+)-PCB95 have opposite effects on alanine and threonine but also predict that (-)-PCB95 plays a more important role when the two enantiomers are administered simultaneously. Glutamic acid, taurine, γ-aminobutyrate, choline, betaine, and phenylalanine increased when embryos were exposed to PCB95, and some of these metabolites increased more in the (-)-PCB95 group than in the other two groups, revealing that the three forms of PCB95 have a similar effect, but the effect of (-)-PCB95 is more intense. Tryptophan, valine, serine, leucine, isoleucine, lysine, proline, and pipecolic acid increased in the racemic and (-)-PCB95 groups but did not differ significantly between the control and (+)-PCB95 groups. Pyroglutamic acid, cysteine, and histidine significantly increased only in the racemic group, which suggests that although a single enantiomer had little influence, the effect is enhanced when the two enantiomers were present as the racemate. In the (+)- and (-)-PCB95 groups, glutamine, tyrosine, and IMP were simultaneously increased; the stable levels of these metabolites in the racemic group indicated antagonism between the two enantiomers. However, aspartate acid increased only in (+)-PCB95 groups compared to the control groups. The differences in above endogenous metabolites suggested enantioselective toxicities between two enantiomers of PCB95.

10.1371/journal.pone.0160584.t003

###### Metabolites selected as biomarkers in the groups treated with chiral PCB95 at a concentration of 1 μg/L.

![](pone.0160584.t003){#pone.0160584.t003g}

  Common Name                                               CK vs rac-PCB95   CK vs (-)-PCB95   CK vs (+)-PCB95   rac- vs (-)-PCB95   rac- vs (+)-PCB95   (-)- vs (+)-PCB95                                                                               
  --------------------------------------------------------- ----------------- ----------------- ----------------- ------------------- ------------------- ------------------- ------- ------- --- ------- ------- --- ------- ------- --- ------- ------- ---
  Alanine[^a^](#t003fn001){ref-type="table-fn"}             1.082             0.015             ↑                 1.221               0.003               ↑                   3.417   0.004   ↓                       1.202   0.000   ↓   0.960   0.000   ↓
  Threonine[^a^](#t003fn001){ref-type="table-fn"}           1.033             0.005             ↑                 0.947               0.026               ↑                   0.976   0.043   ↓                       0.959   0.000   ↓   0.800   0.000   ↓
  Glutamic acid[^a^](#t003fn001){ref-type="table-fn"}       2.116             0.000             ↑                 1.956               0.000               ↑                   0.956   0.000   ↑                                                           
  Taurine[^a^](#t003fn001){ref-type="table-fn"}             2.829             0.001             ↑                 3.378               0.000               ↑                   3.352   0.001   ↑                                                           
  γ-Aminobutyrate[^a^](#t003fn001){ref-type="table-fn"}     0.961             0.000             ↑                 0.980               0.000               ↑                   1.053   0.000   ↑                                           1.003   0.001   ↓
  Choline[^a^](#t003fn001){ref-type="table-fn"}             1.585             0.000             ↑                 1.588               0.000               ↑                   0.966   0.000   ↑                                           1.341   0.034   ↓
  Betaine                                                   2.319             0.012             ↑                 2.589               0.000               ↑                   2.515   0.003   ↑   1.871   0.022   ↑                       2.023   0.029   ↓
  Phenylalanine[^a^](#t003fn001){ref-type="table-fn"}       2.559             0.003             ↑                 2.868               0.000               ↑                   2.17    0.000   ↑   2.281   0.003   ↑   1.481   0.048   ↑                   
  Tryptophan[^a^](#t003fn001){ref-type="table-fn"}          1.020             0.021             ↑                 1.071               0.000               ↑                                       0.959   0.041   ↑                       1.001   0.015   ↓
  Valine[^a^](#t003fn001){ref-type="table-fn"}              1.002             0.017             ↑                 0.773               0.029               ↑                                                           1.808   0.000   ↓   1.577   0.000   ↓
  Serine[^a^](#t003fn001){ref-type="table-fn"}              0.951             0.000             ↑                 1.008               0.002               ↑                                                           1.006   0.000   ↓   0.783   0.001   ↓
  Leucine[^a^](#t003fn001){ref-type="table-fn"}             3.620             0.004             ↑                 1.479               0.009               ↑                                                           1.065   0.001   ↓   3.096   0.003   ↓
  Isoleucine[^a^](#t003fn001){ref-type="table-fn"}          1.256             0.001             ↑                 1.041               0.005               ↑                                                           1.052   0.000   ↓   0.911   0.000   ↓
  Lysine[^a^](#t003fn001){ref-type="table-fn"}              2.073             0.047             ↑                 2.135               0.037               ↑                                                           1.977   0.003   ↓   2.281   0.002   ↓
  Proline[^a^](#t003fn001){ref-type="table-fn"}             2.254             0.000             ↑                 1.580               0.000               ↑                                                           2.648   0.000   ↓   2.421   0.000   ↓
  Pipecolic acid                                            1.177             0.041             ↑                 1.125               0.011               ↑                                                                                               
  Pyroglutamic acid[^a^](#t003fn001){ref-type="table-fn"}   0.916             0.005             ↑                                                                                                 1.734   0.000   ↓   1.597   0.000   ↓                   
  Cysteine[^a^](#t003fn001){ref-type="table-fn"}            0.916             0.000             ↑                                                                                                 1.237   0.000   ↓   1.590   0.000   ↓   1.879   0.004   ↓
  Histidine[^a^](#t003fn001){ref-type="table-fn"}           1.193             0.004             ↑                                                                             2.760   0.000   ↓   0.865   0.001   ↓   0.877   0.000   ↓   0.979   0.000   ↓
  Aspartate acid[^a^](#t003fn001){ref-type="table-fn"}                                                                                                                        2.038   0.015   ↑                                           1.002   0.016   ↑
  Glutamine[^a^](#t003fn001){ref-type="table-fn"}                                                                 2.164               0.000               ↑                   1.578   0.001   ↑   1.507   0.002   ↑                                       
  Tyrosine[^a^](#t003fn001){ref-type="table-fn"}                                                                  1.539               0.000               ↑                   1.505   0.028   ↑   1.336   0.017   ↑                                       
  IMP                                                                                                             0.957               0.026               ↑                   1.564   0.000   ↑                       1.507   0.000   ↑   2.215   0.008   ↑

^a^ Represents the metabolites identified by standards.

^b^ "↑"indicates metabolites that were increased; "↓"indicates metabolites that were decreased

In previous studies of chiral PCB95, enantioselective capacity was observed in other species. For example, the EFs of PCB95 has opposite effects in fish (EF\<0.5) and bivalves (EF \>0.5)\[[@pone.0160584.ref004]\]. Non-racemic enrichment of PCB95 was observed in striped dolphins form the Mediterranean Sea\[[@pone.0160584.ref020]\]. PCB95 are enantioselectively metabolized to OH-PCB95 by cytochrome P450 enzymes in Rat Liver Microsomes\[[@pone.0160584.ref021]\]. Therefore, differential uptake or metabolism of PCB95 enantiomers might be one of the reasons leading to differential metabolite profiles in embryo-larvae zebrafish. However, the actual reasons need to be explored by more experiments in the future.

The experimental results showed that PCB95 treatments have not obvious effects on survival and morbidity of zebrafish larvae, because the investigated cycle was relative short, the number of dead larvae was less than three and the death occurred in one or two of ten replicates of a treated group.

Pathway analysis of the toxic effects of PCB95 {#sec015}
----------------------------------------------

Metabolic pathway analysis by MetaboAnalyst 3.0 was used to determine the most relevant pathways affected by PCB95. The results suggested that fifteen metabolic pathways were measurably perturbed, including glutathione metabolism, phenylalanine, tyrosine, and tryptophan biosynthesis, phenylalanine metabolism, and valine, leucine, and isoleucine biosynthesis ([Table 4](#pone.0160584.t004){ref-type="table"}). The relevant biomarkers and disturbed pathways were summarized from KEGG ([www.genome.jp/kegg/](http://www.genome.jp/kegg/)) to demonstrate the perturbation in zebrafish embryos after exposure ([Fig 4](#pone.0160584.g004){ref-type="fig"}).

10.1371/journal.pone.0160584.t004

###### Disrupted metabolic pathways in zebrafish embryos based on KEGG analysis.

![](pone.0160584.t004){#pone.0160584.t004g}

  No.   KEGG Pathway                                           Hits[^a^](#t004fn001){ref-type="table-fn"}   p[^b^](#t004fn002){ref-type="table-fn"}   FDR            Impact[^c^](#t004fn003){ref-type="table-fn"}
  ----- ------------------------------------------------------ -------------------------------------------- ----------------------------------------- -------------- ----------------------------------------------
  1     Glutathione metabolism                                 1                                            1.56×10^−09^                              4.05×10^−08^   0.01
  2     Phenylalanine, tyrosine, and tryptophan biosynthesis   2                                            9.81×10^−07^                              6.38×10^−06^   1
  3     Phenylalanine metabolism                               2                                            9.81×10^−07^                              6.38×10^−06^   0.41
  4     Aminoacyl-tRNA biosynthesis                            12                                           1.48×10^−06^                              7.70×10^−06^   0.10
  5     Arginine and proline metabolism                        6                                            5.79×10^−05^                              2.51×10^−04^   0.17
  6     Tyrosine metabolism                                    1                                            1.32×10^−04^                              4.30×10^−04^   0.14
  7     Purine metabolism                                      3                                            1.95×10^−04^                              5.63×10^−04^   0.11
  8     Glycine, serine and threonine metabolism               6                                            2.27×10^−04^                              5.90×10^−04^   0.26
  9     Butanoate metabolism                                   1                                            7.38×10^−04^                              1.75×10^−03^   0.03
  10    Glycerophospholipid metabolism                         1                                            8.11×10^−04^                              1.76×10^−03^   0.03
  11    Porphyrin and chlorophyll metabolism                   1                                            3.07×10^−03^                              6.15×10^−03^   0.02
  12    Alanine, aspartate, and glutamate metabolism           3                                            5.64×10^−03^                              1.05×10^−02^   0.26
  13    Methane metabolism                                     1                                            1.02×10^−02^                              1.47×10^−02^   0.4
  14    Taurine and hypotaurine metabolism                     1                                            2.79×10^−02^                              3.63×10^−02^   0.2
  15    Valine, leucine, and isoleucine biosynthesis           3                                            4.64×10^−02^                              5.24×10^−02^   0.67

^a^ "Hits" is the number of matched compounds from the uploaded data in the pathway.

^b^ "*p*" is the original *p* value calculated from pathway enrichment analysis.

^c^ "Impact" is the pathway impact value calculated from the pathway topological analysis.

![Overview of the metabolic pathway network in zebrafish embryos perturbed by PCB95.\
Red-labeled metabolites increased in all PCB95-treated groups, and yellow-labeled metabolites increased and decreased (or stable) across different groups because of enantioselectivity. The solid lines represent direct metabolic reactions, and the dotted lines represent multiple reactions and indirect connections between two metabolites.](pone.0160584.g004){#pone.0160584.g004}

The increase of glutamic acid, γ-aminobutyrate, and histidine in all PCB95 groups, coupled with the increase of glutamine, pyroglutamic acid, tyrosine, aspartate acid, and phenylalanine in the different groups, indicated dysfunction of glutamate-related metabolism in the nervous system. Glutamic acid (Glu), a nonessential amino acid that excites the synapses in the nervous system, is the most abundant neurotransmitter \[[@pone.0160584.ref022],[@pone.0160584.ref023]\]. It is involved in a variety of physiological functions, including synaptic plasticity and cognitive function \[[@pone.0160584.ref024]\]. In addition, Glu can be used for the synthesis of glutamine, which has roles in immune regulation and is required for lymphocyte secretion and proliferation. Glutamine also improves antioxidant capacity, thereby maintaining the stability of the cell membrane and protein structure and protecting vital organs such as the liver, lungs, and intestines \[[@pone.0160584.ref025]\]. Therefore, the observed increases in Glu and glutamine provide evidence for the perturbation of the nervous and immune systems. A significant increase (*p*\< 0.05) in γ-aminobutyrate (GABA), similar to that of Glu, was also observed in all PCB95 groups. GABA, a metabolite of Glu, is a type of inhibitory neurotransmitter \[[@pone.0160584.ref026]\] that has an inhibitory effect on nerve cells overexcitement and plays an important role in suppressing the central nervous system and regulating synapse formation \[[@pone.0160584.ref027]\]. Therefore, the lack of GABA maybe induces anxiety, fatigue, and low resistance. Aspartate acid is a ligand for [NMDA receptors](https://en.wikipedia.org/wiki/NMDA_receptor), and maybe serves as a modulator in neural development process. What's more, aspartate acid has an important role in promoting mitochondria energy metabolism and reducing the liver damage caused by alcohol \[[@pone.0160584.ref028]\]. Disorders of phenylalanine, tryptophan, and tyrosine biosynthesis and phenylalanine metabolism further demonstrate nervous system turbulence. Tryptophan is an essential amino acid that is metabolized via a pathway involving a variety of neural activity metabolites and is a precursor of the neurotransmitters serotonin and melatonin \[[@pone.0160584.ref029]\]. Tyrosine is the precursor of the neurotransmitter dopamine, which can then be converted into [catecholamines](https://en.wikipedia.org/wiki/Catecholamine). Similarly, taurine levels were also significantly increased after treatment with PCB95. Taurine is a kind of neurotransmitter involved in the growth of the nervous system, development of the retina, and absorption of lipids in the digestive tract \[[@pone.0160584.ref030]\].

The increased levels of serine, threonine, cysteine, tryptophan, betaine, and choline in the PCB95 groups suggest disorders of glycine, serine, threonine, and glutathione metabolism, indicating an increase in stress reactions, energy metabolism, and stimulation of nervous and immune systems. Serine is the precursor to several amino acids, including [glycine](https://en.wikipedia.org/wiki/Glycine), [cysteine](https://en.wikipedia.org/wiki/Cysteine) and [tryptophan](https://en.wikipedia.org/wiki/Tryptophan), and also serves as a neuromodulator by coactivating [NMDA receptors](https://en.wikipedia.org/wiki/NMDA_receptor) and inducing the opening of these receptors upon binding. Beyond the central nervous system, D-serine signal transfer plays a signaling role in peripheral tissues and organs such as cartilage, kidney and corpus cavernosum \[[@pone.0160584.ref031]--[@pone.0160584.ref033]\]. Cysteine, an important sulfur-containing amino acid, [serves as a precursor to the antioxidant glutathione](https://en.wikipedia.org/wiki/Cysteine#Precursor_to_the_antioxidant_glutathione) [and iron-sulfur clusters](https://en.wikipedia.org/wiki/Cysteine#Precursor_to_iron-sulfur_clusters), which improve inflammation and adjust the defense mechanism of the organism. N-acetylcysteine has a protective effect against hepatic lipid accumulation in rats exposed to PCB126 \[[@pone.0160584.ref034]\]. Moreover, N-acetylcysteine supplementation reduces the toxicity of PCBs in human breast and prostate epithelial cells and in porcine vascular endothelial cells \[[@pone.0160584.ref035]\]. The underlying mechanism appears to be independent of N-acetylcysteine as a source of cysteine or a precursor of glutathione. Betaine mainly acts as a methyl donor and participates in protein, amino acid, lipid, and nucleic acid metabolism. In addition, betaine exerts an anti-stress effect by promoting the transformation of homocysteine to methionine and strengthening its central inhibitory effects \[[@pone.0160584.ref036]\]. Choline has an affinity for fatty acids, including promoting fatty acid transportation in the form of phospholipids or preventing abnormal accumulation of fatty acids by improving their utilization in the liver \[[@pone.0160584.ref037]\]. The increase of betaine and choline may indicate an increase in fatty acids, which further confirms an abnormal induction of stress reactions and energy metabolism in zebrafish embryos after treatment with PCB95.

Branched-chain amino acid (BCAA) metabolism disturbance was observed in the racemic group and the (-)-PCB95 group, as indicated by increasing valine, leucine, and isoleucine levels. Recent studies have suggested that BCAAs play a vital role in skeletal muscle and the central nervous system. Because BCAA catabolism mainly occurs in skeletal muscles, when the body experiences infection or disease, a large number of muscle proteins decompose into BCAAs as the main source of maintaining the body\'s energy \[[@pone.0160584.ref038]\]. Furthermore, BCAAs are involved in maintaining the neurotransmitter glutamate at a relatively constant level. Excess BCAAs and their derivatives result in neural dysfunction, and humans may be more susceptible to excess BCAAs than rats \[[@pone.0160584.ref039]\].

Excess lysine and pipecolic acid were also observed in the racemic and (-)-PCB95 groups and are probably related to anxiety, immune disorder, and liver injury. Lysine plays an important role in building [muscle](https://en.wikipedia.org/wiki/Muscle) proteins, recovering from [surgery](https://en.wikipedia.org/wiki/Surgery) or sports injuries and the body\'s production of [enzymes](https://en.wikipedia.org/wiki/Enzymes) and [antibodies](https://en.wikipedia.org/wiki/Antibody). Lysine exhibits [anxiolytic](https://en.wikipedia.org/wiki/Anxiolytic) action via its effects on [serotonin](https://en.wikipedia.org/wiki/Serotonin) receptors \[[@pone.0160584.ref040]\] and is related to immunity in chickens \[[@pone.0160584.ref041]\]. Pipecolic acid is a metabolite of lysine and abnormal increases in pipecolic acid are frequently reported in liver cirrhosis and other liver injuries \[[@pone.0160584.ref042]--[@pone.0160584.ref044]\].

Conclusion {#sec016}
==========

In this report, we performed a metabolomics study of zebrafish embryos after exposure to different forms of chiral PCB95 using UPLC-MS/MS combined with multivariate data analysis. This method allowed for detection of 60 metabolites, and the PLS-DA results demonstrated that (-)- and (+)-PCB95 had more prominent effects in zebrafish embryos than the racemate. A total of 26 metabolites, including amino acids, organic acids, nucleosides, betaine, and choline, were selected as potential marker metabolites, and 22 metabolites were identified and quantified by comparison with standards. The biomarker metabolites exhibited different dose-response relationships with increase of doses. Most of the enhanced metabolites tended to increase gradually from the control group to the middle-dose group and then decrease slightly in the high-dose group. Furthermore, the variations of biomarkers were related to the enantiomer-specific variation and enantiomer-specific structures, thus demonstrating enantioselective toxic effects of chiral PCB95 in zebrafish embryos. Fifteen metabolic pathways were significantly affected by PCB95, including glutathione metabolism, phenylalanine, tyrosine, and tryptophan biosynthesis, phenylalanine metabolism, and valine, leucine, and isoleucine biosynthesis. Many nervous and immune system-related metabolites were confirmed to be significantly altered by exposure to PCB95, indicating that the toxic effects of PCB95 may be related to its interactions with the nervous and immune systems, disorders of energy metabolism, and disruption of liver function.
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